Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study

Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study

Masumi G Asahi, Josh Wallsh, Spencer M Onishi, Shari Kuroyama, Ron P Gallemore Clinical Research Department, Retina Macula Institute, Torrance, CA, USACorrespondence: Ron P Gallemore Tel +1 (310) 944-9393Fax +1 (310) 944-3393Email rongallemoremd@gmail.comPurpose: To compare monthly versus pro re nat...

Full description

Bibliographic Details
Main Authors: Asahi MG, Wallsh J, Onishi SM, Kuroyama S, Gallemore RP
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Clinical Ophthalmology
Subjects:
age-related macular degeneration
microperimetry
multifocal erg
ranibizumab
Online Access:https://www.dovepress.com/multifocal-erg-and-microperimetry-changes-in-response-to-ranibizumab-t-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/multifocal-erg-and-microperimetry-changes-in-response-to-ranibizumab-t-peer-reviewed-article-OPTH

Similar Items